Fda mandating dose counters

Rated 4.66/5 based on 859 customer reviews

(Michelle Tribe via Wikimedia Commons) Apparently, a Food and Drug Administration warning four months ago was missed by many physicians, pharmacists and patients, so the agency, in an unusual move, saw fit Monday to remind us: Stop writing prescriptions for, stop dispensing prescriptions for, and stop taking prescription medications containing more than 325 milligrams of acetaminophen.

Your liver will thank you -- acetaminophen overdose has overtaken viral hepatitis infection as the most common cause of acute liver failure.

"Selecting the most appropriate therapy based on individual patient preference is an important consideration for healthcare professionals as high cholesterol treatment often requires long-term management." "Many patients in the continue to struggle with high levels of bad cholesterol, or LDL cholesterol, despite diet, exercise and other lipid-lowering therapies, so new dosing options are welcome additions to the treatment landscape," said Corinne Hanotin, M. "Praluent is now the only PCSK9 inhibitor to offer two dosage strengths with two levels of efficacy, as well as a monthly dosing option." The 300 mg dose is administered via two 150 mg injections at two different injection sites.

Or maybe not, because the FDA does not usually have to repeat itself.

The agency is also recommending that pharmacists who receive prescriptions for drugs with more than the 325mg per dose call the prescribing physician and inform him of the FDA’s new warning.

(alirocumab) Injection for the treatment of adults with high low-density lipoprotein (LDL) cholesterol.

In 2011, the agency asked manufacturers of acetaminophen-combined prescription drugs to limit the amount of acetaminophen to no more than 325mg by 2014.

More than half have agreed, but medications with higher amounts are still on the market.

Leave a Reply